If the board is honest to the extent of saying exactly where they are up to with production(without naming names of drugs or companies)if that is possible,along with full disclosure of cost cutting and direction,then I am hoping that will be enough to lift the sp.
If the mushroom approach continues,who knows what will happen.
Earning call next month, will this boost SP?, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)